Menene ergothioneine, kuma me ya sa ake kiransa "vitamin ɗin dogon rayuwa"?
Ergothioneine (ET) sinadarin amino acid ne mai dauke da sulfur (thione) wanda jikin mutum ba ya iya ƙirƙirarsa. Sai dai ana samun sa ta abinci, kuma ƙwaro ne daga cikin manyan abincin da ke ɗauke da shi. Jikinmu na da ƙwayar karɓar wannan sinadari ta musamman, shi ya sa masana suka yi masa lakabi da "vitamin ɗin dogon rayuwa."
Ba a yarda a kirkiro “vitamin” don abu da ba ya da tasiri ba – amma kasancewar ET yana da matuƙar amfani a jiki ya sa aka ɗauke shi a matsayin muhimmin nutrient. Har yanzu ana nazarin ET a matsayin anti‑oxidant da mai kare ƙwayoyin, amma aikin da muka samu a cikin wannan bincike ya nuna cewa ET ba wai kawai “mai tsarkakewa” ba ne, har ma yana kafa siginar kwayoyin – wani ɓangare da masu sha'awar bio‑hacking za su iya kulawa da shi.
Sakamakon a ciyawar C. elegans: tsawon rai da motsi mafi inganci
Masana suka fara gwada ET a Caenorhabditis elegans, ƙwanƙolin da aka fi amfani da shi wajen binciken tsufa.
- ET ta tsawaita rayuwar ciyawar kuma ta inganta motsin su lokacin da suka tsufa.
- Ciyawar da aka ba da magani sun nuna ƙarin juriya ga damuwa da rage alamun da ke bayyana da tsufa.
Wannan sakamako yana daga cikin matakan farko da ake samu a ciyawar, amma ba koyaushe ne ke haifar da canji iri ɗaya a dabbobi masu girma kamar beraye ba. Saboda haka an ɗauki ET a matsayin abin da za a yi ƙoƙarin gwadawa a berayen.
Sakamakon a berayen tsofu: juriya, ƙarfi a tsoka, da NAD+
Berayen da suka tsufa (kimanin watanni bakwai) aka ba su ET tsawon makonni huɗu, ƙungiyar ta lura da waɗannan canje‑canje:
- Ƙara juriya a treadmill – berayen sun yi tafiya mai nisa a kan treadmill fiye da wadanda ba a ba su ET ba.
- Ƙara ƙarfin tsoka – an ga ƙaruwa a ƙarfin da tsokoki ke nuna a gwajin igiya.
- Ƙara yawan jijiyoyin jini a cikin tsoka – wato ƙaruwar cibiyoyin jini da ke ba da iskar oxygen da abinci ga tsoka.
- Ƙaruwa a matakin NAD+ a tsoka – NAD+ na raguwa da tsufa, kuma yana da mahimmanci ga aikin mitochondria. Haihuwa a cikin tsoka na nuni da tasiri kan sarcopenia (raƙumin ƙarfi a tsokoki).
Mabudin dabarar: yadda ET ke haɓaka NAD+ ta hanyar H₂S
Marubutan sun gano cewa ba kawai ET ke ƙara NAD+ kai tsaye ba; yana aiki ne a cikin wani tsari na kwayoyin da ke ƙara samar da hydrogen sulfide (H₂S). Ga matakan da suka bayyana:
- CSE (cystathionine γ‑lyase) na ƙara samar da H₂S – ET na ba da ƙarin ƙarfin CSE, ko a ce yana “madadin sinadari” wanda ke ƙara fitar da H₂S.
- H₂S na bai wa proteins alamar persulfidation – wannan canjin kimiyya na ƙara sulfide a kan cysteine residues, yana sauya yadda protein ke aiki. An gano fiye da ƙwayoyin 300 da aka persulfidate.
- cGPDH (cytosolic glycerol‑3‑phosphate dehydrogenase) na kunnawa – ɗayan waɗannan target, cGPDH, an kunna shi ta persulfidation. cGPDH yana cikin hanyoyin shuttle da ke taimakawa sake samar da NAD⁺ daga NADH a cytoplasm.
- NAD⁺ na tashi – kunna cGPDH shi ne tushen haɓakar NAD⁺ da ET ta haifar.
Hujojinsa an nuna ta gwajin knockout: Idan aka cire CSE ko cGPDH, tasirin ET ya Ɂoyan gaba ɗaya. Wannan yana tabbatar da cewa hanyar da aka gano ba wani abu ne da ba a sarrafa ba, sai dai wata hanya mai mahimmanci.
Yaya wannan ke kwatanta da NMN da NR?
NMN da NR su ne precursors na hanyar NAD⁺ salvage – suna ba da kayan gini ga sel don sake ƙirƙirar NAD⁺. A gefe guda, ET ba yana ba da kayan gini ba; yana kafa siginar redox wadda ke kunna enzyme (cGPDH) don samar da NAD⁺ daga NADH. Hanyoyin biyu na iya cika juna, amma har yanzu ba a yi ƙididdigar haɗin kai a cikin gwaje‑gwaje ba. Takardar ba ta ƙunshi gwajin kai tsaye tsakanin NMN/NR da ET ba, don haka kowanne iƙirari na “ET ya fi” ko “ya fi haɗi da su” ya rage ga tunani.
Abubuwan da za a iya amfani da su ga masu sha'awa
- Abincin da ke da yawa ET – ƙwaro ne mafi yawan ET, musamman shiitake, king oyster, shiitake, da porcini. A ƙananan adadi ana samun ET a wasu wake, oat bran, da nama. Dafa abinci ba ya lalata ET sosai.
- Kayan kari (supplement) na ET – yawanci suna ba da 5 – 25 mg a kowace rana. Wannan shine adadin da ake amfani da shi a gwaje‑gwajen kan mutane.
- Adadin da aka yi amfani da shi a beraye – a cikin gwajin, berayen sun karɓi kusan 200 – 260 mg a kowace rana idan aka fassara zuwa mutum, wato kusan sau goma na adadin da ake ba da shi a ƙwayoyin ƙaruwa. Ko wannan adadi yana da aminci ko kuma yana da tasiri a mutane ba a tabbatar ba. Takardar ba ta nuna cewa kashi 5‑25 mg na ƙwallon zai iya haɓaka NAD⁺ a tsoka ga mutum ba.
Babban gargadi: dabbobi kawai, ba a samu hujja a mutane ba tukuna
Ku kasance masu shakku game da duk wani tsammani da aka yi na ƙwarai ga mutane:
- Babu bayanan mutum – Binciken ya ƙunshi ciyawa, beraye, da ƙwayoyin sel.
- Bambancin adadi – Adadin da ya haifar da tasiri a beraye, idan aka juya zuwa matsakaicin mutum, ya ninka sau goma adadin da ake amfani da shi a yau da kullum.
- Tsawon lokaci ba a sani ba – Ba a tabbatar da sakamakon dogon lokaci, amincin adadi mai yawa, ko tasirin a rayuwar mutane ba.
- NAD⁺ a tsoka ba alamar kiwon lafiya kai tsaye ba – Ƙara NAD⁺ a tsoka da ƙara ƙarfi a treadmill alamu ne masu kyau a beraye, amma ba hujja ce ta tsawon rai ko lafiyar gabaɗaya a mutane ba.
- Hujja tana buƙatar gwajin mutum – Hanya kimiyya ce mai kyau don gudanar da gwaji, ba madadin gwajin mutum ba.
Kammalawa
Wannan takarda ta fayyace ainihin hanyar da ergothioneine ke amfani da ita: haɗin CSE → H₂S → persulfidation → cGPDH → NAC⁺. Wannan mataki ne da ya wuce tunanin “anti‑oxidant kawai.” Cin ƙwaro ko shan kari na ET wata hanya ce mai sauƙi, amma har yanzu ba mu da hujjar da ta tabbatar da cewa zai ƙara NAD⁺ ko rage alamar tsufa a mutane. Wannan zai kasance a kan gwaje‑gwajen mutane da za su zo nan gaba.
